HIV coinfection with hepatitis b other diagnostic studies: Difference between revisions
Created page with "__NOTOC__ {{HIV coinfection with hepatitis b}} {{CMG}} ==Liver Biopsy== Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-inv..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Liver Biopsy== | ==Other Diagnostic Studies== | ||
===Liver Biopsy=== | |||
Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients. | Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients. | ||
Revision as of 15:57, 7 December 2012
|
HIV coinfection with hepatitis b Microchapters |
|
Differentiating HIV coinfection with hepatitis b from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV coinfection with hepatitis b other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of HIV coinfection with hepatitis b other diagnostic studies |
|
FDA on HIV coinfection with hepatitis b other diagnostic studies |
|
CDC on HIV coinfection with hepatitis b other diagnostic studies |
|
HIV coinfection with hepatitis b other diagnostic studies in the news |
|
Blogs on HIV coinfection with hepatitis b other diagnostic studies |
|
Directions to Hospitals Treating HIV coinfection with hepatitis b |
|
Risk calculators and risk factors for HIV coinfection with hepatitis b other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Other Diagnostic Studies
Liver Biopsy
Liver biopsy remains the gold standard for assessing disease severity in HIV-HBV coinfection. Non-invasive markers are also available but none have been widely studied in coinfected patients.